Boceprevir

This classification denotes a protease inhibitor and antiviral with the molecular formula C27H45N5O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 89BT58KELH, chemically known as (1R,2S,5S)-N-(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)-3-[(2S)-2-(tert-butylcarbamoylamino)-3,3-dimethylbutanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide but generally known as Boceprevir, which bears US NIH Compound Identifier 10324367. Boceprevir most often comes in base and sulfate forms. European Medicines Agency schedules Boceprevir in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB31579. The term BOCEPREVIR is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 22, No. 1, 2008, List 59.). As of Q4 2014, BOCEPREVIR remains the US FDA Preferred Term for this commodity. SMILES: CC1(C2C1C(N(C2)C(=O)C(C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)NC(CC3CCC3)C(=O)C(=O)N)C.